Goldenwell Biotech, Inc.
GWLL · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $20 | $6 | $28 | $27 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $20 | $6 | $28 | $27 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -94.1% | -95.1% | 199.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 46% | 47.4% | 52.7% | 52.5% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -88,559.7% | 0% | 0% | 0% |
| Net Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | -94,602.9% | -4,995.5% | -2,060.9% | -732.6% |
| EPS Diluted | -0.001 | -0.001 | -0.01 | -0.001 |
| % Growth | -8.3% | 88.2% | -684.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | -$0 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$0 |